This month, the US EPA proposed new requirements for its New Source Performance Standards (NSPS) for methane and volatile organic compounds (VOC) emissions for new and modified oil and gas sources. The proposal extends previous methane and VOC emissions requirements to hydraulically fractured oil wells and natural gas transmissions, including pneumatic pumps, and well sites […]
The nonprofit Center for Medical Technology Policy’s Green Park Collective, a multistakeholder forum, has released a draft of its initial guidelines for insurance coverage of NGS-based oncology testing. The guidelines recommend coverage of NGS panels of 5–50 genes that include a subset of genes that “are considered to be standard of care and medically necessary […]
The consolidation of drug distributors is resulting in mergers among manufacturers of generic drugs. In the US, four companies buy the majority of generics, and generic-drug firms could merge to increase their abilities to negotiate with distributors. Merging may also help the companies face the costs of heightened examination of the industry by US regulators […]
In 2014, the top 50 chemical companies’ sales totaled $961.3 billion, declining less than 1% from last year’s $965.1 billion. The loss was in line with falling chemical prices resulting from the drop in oil prices. In general, specialty chemical companies fared better than petrochemical firms. The combined operating income of the 44 public companies […]
This month, US President Obama and the EPA unveiled the Clean Power Plan, which regulates emissions from new, modified and reconstructed power plants. The Plan, when fully implemented, calls for carbon, sulfur dioxide and nitrogen oxides emissions from power plants to be reduced nationally to 32%, 90% and 72% below 2005 levels, respectively. States must […]
The steel industry is experiencing globalization, with causes including excess production capacity, the highest of which is in China. Worldwide growth in steel demand slowed to 0.6% in 2014, with 0.5% growth in demand predicted by the World Steel Association in 2015. Correspondingly, in 2014, global steel production experienced a slowdown in growth to 1.2%. […]
Seven federal agencies—the Department of Defense (DOD), DOE’s National Nuclear Security Administration (NNSA), FDA, NIH, NIST, NSF and Department of Veterans Affairs (VA)—conducted or funded research in regenerative medicine from fiscal 2012–14 (FY12–14). The agencies invested about $2.89 billion in the research during this time, with the NIH accounting for about 88% of this spending. […]
The oil industry continues to cut costs as crude oil prices remain depressed. The cuts are now spreading to oil producers, having initially affected oilfield service companies starting a year ago. Graves & Co. estimates that the oil industry has shed more than 150,000 jobs. Providers of oilfield services and drilling contractors have accounted for […]
The pharmaceutical industry’s investment in personalized medicine has jumped almost 90% in the last five years. Developers of diagnostic tests, many with FDA approval of their diagnostic devices, are working with pharmaceutical companies to codevelop drugs and companion diagnostics. This may speed up FDA approval of drugs, as the best-suited patients can be selected for […]
This month, the US government issued a memo on updating the regulation of biotech products—products obtained through genetic engineering or organisms resulting from targeted gene manipulation. The update will address the fact that each federal agency dealing with biotech products (the EPA, FDA and USDA) currently has its own regulations and guidance, and that science […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
